0001179110-20-005127.txt : 20200424
0001179110-20-005127.hdr.sgml : 20200424
20200424212937
ACCESSION NUMBER: 0001179110-20-005127
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200422
FILED AS OF DATE: 20200424
DATE AS OF CHANGE: 20200424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howell Kelli Mari
CENTRAL INDEX KEY: 0001734485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52024
FILM NUMBER: 20816996
BUSINESS ADDRESS:
BUSINESS PHONE: 1-760-431-9286
MAIL ADDRESS:
STREET 1: C/O ALPHATEC SPINE, INC.
STREET 2: 5818 EL CAMINO REAL
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alphatec Holdings, Inc.
CENTRAL INDEX KEY: 0001350653
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 202463898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5818 EL CAMINO REAL
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 760-431-9286
MAIL ADDRESS:
STREET 1: 5818 EL CAMINO REAL
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
edgar.xml
FORM 4 -
X0306
4
2020-04-22
0
0001350653
Alphatec Holdings, Inc.
ATEC
0001734485
Howell Kelli Mari
C/O ALPHATEC SPINE, INC.
5818 EL CAMINO REAL
CARLSBAD
CA
92008
0
1
0
0
EVP, Clinical Strategies
Common Stock
2020-04-22
4
A
0
98534
0
A
500549
D
On April 22, 2020, issuer granted to the reporting person 98,534 restricted stock units (RSUs), subject to receipt of required approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by at least such number as is necessary to vest all of the awards granted on April 22, 2020. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date; provided, however, that the vesting of 50% of these RSUs is subject to the additional condition that the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $7.52 per share during the first three years following the grant date. Should the publicly-traded stock price for the issuer's common stock reach a 30-day average trading price at or above $7.52 per share at any time during such three year period, this pricing condition will be satisfied and will terminate.
Each RSU represents a contingent right to receive one share of the issuer's common stock.
/s/ Kelli M. Howell
2020-04-24